Endometrial Cancer Recurrent
9 clinical trials · Condition
◉ Watch Endometrial Cancer Recurrent
| Record | Firm | Date |
|---|---|---|
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors (NCT05410717) | Second Affiliated Hospital of Guangzhou Medical University | 2022-06-01 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer (NCT03485729) | Jazz Pharmaceuticals | 2018-03-21 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer (NCT02922764) | Inspirna, Inc. | 2016-11-01 |
Track Endometrial Cancer Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.